ARDS and COVID-19 in an LVAD Patient: Should We Look at Percent Change in LDH, Ferritin and CRP Values in A Cytokine Storm to Assess Severity? What Cardiac Manifestations Do We Need to Keep an Eye on?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

ARDS and COVID-19 in an LVAD Patient: Should We Look at Percent Change in LDH, Ferritin and CRP Values in A Cytokine Storm to Assess Severity? What Cardiac Manifestations Do We Need to Keep an Eye on?

By Mount Sinai FEATURING Kiran Mahmood, John Chau, Anuradha Lala-Trindade, Sean Pinney, Estefania Oliveros

608 views

May 25, 2020

3 Comments

Post COVID-19 Lung Complications

Feat. M. Padilla

21:26

Hassan Bencheqroun MD FCCP

COVID-19 & ICU FAQ Answered: When Should We Intubate & How D…

24:48

Stanford Medicine

Acute & Long-Term Cardiac Effects of COVID-19

Feat. E. Profita

09:50

The Cardiogenic Shock Working Group

Hemodynamic vs. Hemo-Metabolic Shock: Redefining Shock Profiles

Feat. N. Kapur

17:36

Mount Sinai Advanced Innovations in Heart Failure

Contemporary Management of Cardiogenic Shock: Updates in 2022

Feat. D. Baran

11:07

Northwestern Medicine Cardiovascular Care

What Are the Considerations for Management of ST-Elevation Myocardia…

Feat. R. Bach

13:53

American Heart & Vascular Institute

Cardiogenic Shock: Should IABP or PVADs Be Used in Cardiogenic Shock?

Feat. M. Ansari

16:00

24th Annual Heart Failure 2020: an Update on Therapy

COVID-19 and Heart Failure

Feat. M. Mehra

20:59

UChicago Medicine

Timing and Choice of Percutaneous Mechanical Circulatory Support (pM…

Feat. S. Nathan

65:03

Abiomed

TNL a Closer Look at Operationalizing a Heart Team Approach

Feat. J. Rommel, P. Kane

06:49

Mount Sinai

COVID-19: What Types of Thrombosis Are Commonly Seen? Are Anticoagul…

Feat. J. Olin

15:15

Joseph Thomas

The Other Option for Hemodynamic Support in High Risk PCI

22:46

Houston Methodist DeBakey Heart and Vascular Center

COVID-19 and Heart Failure: How to Evaluate Patients? Can You Give B…

Feat. N. Fida

22:19

UCLA Health

What We Learned from COVID-19

Feat. O. Emeruwa

14:36

Abiomed

CAMP - Impella RP in RV Shock Case - Tanmay Swadia, Michigan Heart

Feat. T. Swadia

18:48

Complex Coronary Cases

Cardiogenic Shock: All Mechanical Circulatory Support Devices

Feat. G. Serrao

18:12

Keck School of Medicine of USC

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for …

Feat. L. Clavijo

40:45

The Texas Heart Institute

Heart Failure Related Cardiogenic Shock: Untangling the Spiral of He…

Feat. J. Hernandez-Montfort

33:33

Georgia Heart Institute

Debate: LVAD or Transplant – First Line of Therapy for AdvancedHeart…

Feat. D. Baran, J. Lindenfeld, U. Egolum

11:57

St. Louis Shock & Heart Failure Symposium 2022

Strategies for Temporary MCS: Impeller-Based ECLS in Cardiogenic Sho…

Feat. K. Kotkar

Login

Login

Join VuMedi

ARDS and COVID-19 in an LVAD Patient: Should We Look at Percent Change in LDH, Ferritin and CRP Values in A Cytokine Storm to Assess Severity? What Cardiac Manifestations Do We Need to Keep an Eye on?

Related Content